Position in NRXP
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,286,955
+$626,417 QoQ
Shares Held
314,659
+1.5% QoQ
Ownership
0.727%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 47 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRXP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. NRXP ranks #305 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in NRXP
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,286,955 | 314,659 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $660,538 | 310,112 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $593,125 | 218,866 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $613,343 | 185,862 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $561,550 | 172,255 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $276,046 | 134,657 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $163,352 | 74,251 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $130,705 | 77,341 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $160,207 | 65,659 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $198,218 | 419,954 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $189,484 | 411,922 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $107,099 | 411,922 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $183,274 | 378,667 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $249,541 | 378,667 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $420,320 | 378,667 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $237,263 | 320,627 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $185,059 | 308,432 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $719,974 | 293,867 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,010,970 | 211,500 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $424,250 | 45,766 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $400,599 | 34,475 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||